Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351

1.

Cross-sectional study of the association between day-to-day home blood pressure variability and visceral fat area measured using the dual impedance method.

Kuwabara J, Kuwahara K, Kuwabara Y, Yasuno S, Nakagawa Y, Ueshima K, Kimura T.

PLoS One. 2018 Nov 5;13(11):e0206945. doi: 10.1371/journal.pone.0206945. eCollection 2018.

2.

Achieving LDL-C target levels less than 70 mg/dL may provide extra cardiovascular protection in high-risk patients: exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients With Hypercholesterolemia and Diabetic Retinopathy Study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Obes Metab. 2018 Nov 4. doi: 10.1111/dom.13575. [Epub ahead of print]

PMID:
30393955
3.

Is the alignment guide technique in total hip arthroplasty sufficient for accurate cup positioning with a modified Watson Jones approach?

Yoshitani J, Nakamura T, Maruhashi Y, Hashimoto N, Sasagawa T, Ueshima K, Funaki K.

J Orthop Surg (Hong Kong). 2018 May-Aug;26(3):2309499018806645. doi: 10.1177/2309499018806645.

PMID:
30352543
5.

[Contribution of pharmacological research to the discovery of a first-in-class drug, mirabegron, for the treatment of overactive bladder].

Ueshima K, Ukai M.

Nihon Yakurigaku Zasshi. 2018;152(3):111-118. doi: 10.1254/fpj.152.111. Japanese.

PMID:
30185728
6.

Radiosensitizing Effect of 5-Aminolevulinic Acid and Protoporphyrin IX on Carbon-ion Beam Irradiation.

Kaneko T, Tominaga M, Kouzaki R, Hanyu A, Ueshima K, Yamada H, Suga M, Yamashita T, Okimoto T, Uto Y.

Anticancer Res. 2018 Jul;38(7):4313-4317. doi: 10.21873/anticanres.12730.

PMID:
29970567
7.

Effect of ASP6432, a Novel Type 1 Lysophosphatidic Acid Receptor Antagonist, on Urethral Function and Prostate Cell Proliferation.

Sakamoto K, Noguchi Y, Ueshima K, Yamakuni H, Ohtake A, Sato S, Ishizu K, Hosogai N, Kawaminami E, Takeda M, Masuda N.

J Pharmacol Exp Ther. 2018 Aug;366(2):390-396. doi: 10.1124/jpet.118.247908. Epub 2018 Jun 8.

PMID:
29884626
8.

Total resection of any segment of the lateral meniscus may cause early cartilage degeneration: Evaluation by magnetic resonance imaging using T2 mapping.

Murakami K, Arai Y, Ikoma K, Kato K, Inoue H, Nakagawa S, Fujii Y, Ueshima K, Fujiwara H, Kubo T.

Medicine (Baltimore). 2018 Jun;97(23):e11011. doi: 10.1097/MD.0000000000011011.

9.

Long-term effects of antihypertensive therapy on cardiovascular events and new-onset diabetes mellitus in high-risk hypertensive patients in Japan.

Liu J, Yasuno S, Oba K, Konda M, Ichihara C, Kitao H, Kuwabara Y, Ueshima K.

J Hypertens. 2018 Sep;36(9):1921-1928. doi: 10.1097/HJH.0000000000001780.

PMID:
29750680
10.

Evaluation of femoral perfusion using dynamic contrast-enhanced MRI after simultaneous initiation of electrical stimulation and steroid treatment in an osteonecrosis model.

Yamamoto H, Ueshima K, Saito M, Ikoma K, Ishida M, Goto T, Hayashi S, Ikegami A, Fujioka M, Mazda O, Kubo T.

Electromagn Biol Med. 2018;37(2):84-94. doi: 10.1080/15368378.2018.1466310. Epub 2018 Apr 30.

PMID:
29708772
11.

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.

Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N, Aikata H, Nagano H, Hatano E, Sasaki Y, Hino K, Kumada T, Yamamoto K, Imai Y, Iwadou S, Ogawa C, Okusaka T, Kanai F, Akazawa K, Yoshimura KI, Johnson P, Arai Y; SILIUS study group.

Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432. doi: 10.1016/S2468-1253(18)30078-5. Epub 2018 Apr 7.

PMID:
29631810
12.

Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Care. 2018 Jun;41(6):1275-1284. doi: 10.2337/dc17-2224. Epub 2018 Apr 6.

PMID:
29626074
13.

Early detection of osteoarthritis in rabbits using MRI with a double-contrast agent.

Onishi O, Ikoma K, Kido M, Kabuto Y, Ueshima K, Matsuda KI, Tanaka M, Kubo T.

BMC Musculoskelet Disord. 2018 Mar 13;19(1):81. doi: 10.1186/s12891-018-2002-1.

14.

Sustained antiviral effects and clearance of hepatitis surface antigen after combination therapy with entecavir and pegylated interferon in chronic hepatitis B.

Hagiwara S, Nishida N, Watanabe T, Ida H, Sakurai T, Ueshima K, Takita M, Komeda Y, Nishijima N, Osaki Y, Kudo M.

Antivir Ther. 2018 Feb 13. doi: 10.3851/IMP3225. [Epub ahead of print]

PMID:
29438098
15.

Effectiveness of nationwide screening and lifestyle intervention for abdominal obesity and cardiometabolic risks in Japan: The metabolic syndrome and comprehensive lifestyle intervention study on nationwide database in Japan (MetS ACTION-J study).

Nakao YM, Miyamoto Y, Ueshima K, Nakao K, Nakai M, Nishimura K, Yasuno S, Hosoda K, Ogawa Y, Itoh H, Ogawa H, Kangawa K, Nakao K.

PLoS One. 2018 Jan 9;13(1):e0190862. doi: 10.1371/journal.pone.0190862. eCollection 2018.

16.

Effects of monthly feedback of VFA measured by dual BIA method in Japanese patients with obesity: a randomized controlled study.

Moriyasu T, Hosoda K, Tanaka-Mizuno S, Konda M, Ueshima K, Ida M, Nin K.

Obes Sci Pract. 2017 Sep 14;3(4):407-416. doi: 10.1002/osp4.126. eCollection 2017 Dec.

17.

Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study.

Ogawa C, Morita M, Omura A, Noda T, Kubo A, Matsunaka T, Tamaki H, Shibatoge M, Tsutsui A, Senoh T, Nagano T, Takaguchi K, Tani J, Morishita A, Yoneyama H, Masaki T, Moriya A, Ando M, Deguchi A, Kokudo Y, Minami Y, Ueshima K, Sakurai T, Nishida N, Kudo M.

Oncology. 2017;93 Suppl 1:113-119. doi: 10.1159/000481241. Epub 2017 Dec 20.

18.

Fixed-flexion view X-ray of the knee superior in detection and follow-up of knee osteoarthritis.

Kan H, Arai Y, Kobayashi M, Nakagawa S, Inoue H, Hino M, Komaki S, Ikoma K, Ueshima K, Fujiwara H, Yokota I, Kubo T.

Medicine (Baltimore). 2017 Dec;96(49):e9126. doi: 10.1097/MD.0000000000009126.

19.

Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.

Minami Y, Minami T, Hagiwara S, Ida H, Ueshima K, Nishida N, Murakami T, Kudo M.

Eur Radiol. 2018 May;28(5):1986-1993. doi: 10.1007/s00330-017-5162-8. Epub 2017 Dec 1.

PMID:
29196855
20.

Evaluation of NISHIJIN e-textile for 12-lead ECG measurement through automatic ECG analyzer.

Kuroda T, Shiomi H, Minamino-Muta E, Yamashita Y, Iwao T, Tamura H, Ueshima K, Kimura T.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:1234-1237. doi: 10.1109/EMBC.2017.8037054.

PMID:
29060099
21.

Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience.

Ueshima K, Nishida N, Kudo M.

Dig Dis. 2017;35(6):611-617. doi: 10.1159/000480257. Epub 2017 Oct 17.

PMID:
29040994
22.

Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2.

Arizumi T, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Kamata K, Minaga K, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M.

Dig Dis. 2017;35(6):589-597. doi: 10.1159/000480208. Epub 2017 Oct 17.

PMID:
29040992
23.

Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2.

Arizumi T, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Kamata K, Minaga K, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M.

Dig Dis. 2017;35(6):583-588. doi: 10.1159/000480186. Epub 2017 Oct 17.

PMID:
29040991
24.

Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection.

Ida H, Hagiwara S, Kono M, Minami T, Chishina H, Arizumi T, Takita M, Yada N, Minami Y, Ueshima K, Nishida N, Kudo M.

Dig Dis. 2017;35(6):565-573. doi: 10.1159/000480183. Epub 2017 Oct 17.

PMID:
29040989
25.

Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals.

Kono M, Nishida N, Hagiwara S, Minami T, Chishina H, Arizumi T, Minaga K, Kamata K, Komeda Y, Sakurai T, Takenaka M, Takita M, Yada N, Ida H, Minami Y, Ueshima K, Watanabe T, Kudo M.

Dig Dis. 2017;35(6):556-564. doi: 10.1159/000480148. Epub 2017 Oct 17.

PMID:
29040988
26.

Hepatocarcinogenesis Is Associated with Serum Albumin Levels after Sustained Virological Responses with Interferon-Based Therapy in Patients with Hepatitis C.

Umehara Y, Hagiwara S, Nishida N, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Chishina H, Ueshima K, Komeda Y, Arizumi T, Watanabe T, Kudo M.

Dig Dis. 2017;35(6):548-555. doi: 10.1159/000480147. Epub 2017 Oct 17.

PMID:
29040987
27.

Atriofascicular Mahaim with Ebstein anomaly: A case report.

Ueshima K, Nakamura Y, Takeno S, Miyake T, Takemura T.

J Arrhythm. 2017 Oct;33(5):508-510. doi: 10.1016/j.joa.2017.06.007. Epub 2017 Aug 8.

28.

Changes in Basic Movement Ability and Activities of Daily Living After Hip Fractures: Correlation Between Basic Movement Scale and Motor-Functional Independence Measure Scores.

Toyama S, Sawada K, Ueshima K, Mikami Y, Mori I, Takamuku K, Takahashi T, Kubo T.

Am J Phys Med Rehabil. 2018 May;97(5):316-322. doi: 10.1097/PHM.0000000000000829.

PMID:
28930758
29.

Evidence and topics of chemotherapy for hepatocellular carcinoma.

Ueshima K, Kudo M.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(9):1621-1628. doi: 10.11405/nisshoshi.114.1621. Japanese. No abstract available.

PMID:
28883291
30.

Length change patterns and shape of a grafted tendon after anatomical medial patellofemoral ligament reconstruction differs from that in a healthy knee.

Nakagawa S, Arai Y, Inoue H, Hino M, Fujii Y, Komaki S, Ikoma K, Ueshima K, Fujiwara H, Kubo T.

Knee Surg Sports Traumatol Arthrosc. 2018 Apr;26(4):1245-1251. doi: 10.1007/s00167-017-4620-9. Epub 2017 Jul 24.

PMID:
28741155
31.

The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization.

Arizumi T, Ueshima K, Iwanishi M, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M.

Liver Cancer. 2017 Jun;6(3):227-235. doi: 10.1159/000475777. Epub 2017 May 9.

32.

Reliability of radiographic evaluations of the stage of osteoarthritis of the hip joint and an approach to improve the staging criteria.

Yoshitani J, Nakamura T, Ueshima K, Ebara H, Kabata T, Tsuchiya H.

J Orthop Sci. 2017 Sep;22(5):905-908. doi: 10.1016/j.jos.2017.05.007. Epub 2017 May 24.

PMID:
28551281
33.

Underuse of Cardiac Rehabilitation in Workers With Coronary Artery Disease - Claims Database Survey in Japan.

Kanazawa N, Ueshima K, Tominari S, Nakayama T.

Circ J. 2017 Sep 25;81(10):1424-1431. doi: 10.1253/circj.CJ-16-1260. Epub 2017 May 11.

34.

Radiographic Measurement of Joint Space Width Using the Fixed Flexion View in 1,102 Knees of Japanese Patients with Osteoarthritis in Comparison with the Standing Extended View.

Kan H, Arai Y, Kobayashi M, Nakagawa S, Inoue H, Hino M, Komaki S, Ikoma K, Ueshima K, Fujiwara H, Kubo T.

Knee Surg Relat Res. 2017 Mar 1;29(1):63-68. doi: 10.5792/ksrr.16.046.

35.

Proposal of quality indicators for cardiac rehabilitation after acute coronary syndrome in Japan: a modified Delphi method and practice test.

Ohtera S, Kanazawa N, Ozasa N, Ueshima K, Nakayama T.

BMJ Open. 2017 Jan 27;7(1):e013036. doi: 10.1136/bmjopen-2016-013036.

36.

Influence of Liver Inflammation on Liver Stiffness Measurement in Patients with Autoimmune Hepatitis Evaluation by Combinational Elastography.

Yada N, Sakurai T, Minami T, Arizumi T, Takita M, Hagiwara S, Ida H, Ueshima K, Nishida N, Kudo M.

Oncology. 2017;92 Suppl 1:10-15. doi: 10.1159/000451011. Epub 2017 Jan 6.

37.

Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity.

Nakao K, Kuwahara K, Nishikimi T, Nakagawa Y, Kinoshita H, Minami T, Kuwabara Y, Yamada C, Yamada Y, Tokudome T, Nagai-Okatani C, Minamino N, Nakao YM, Yasuno S, Ueshima K, Sone M, Kimura T, Kangawa K, Nakao K.

Hypertension. 2017 Feb;69(2):286-296. doi: 10.1161/HYPERTENSIONAHA.116.08219. Epub 2017 Jan 3.

PMID:
28049696
38.

Malignant Transformation of Hepatocellular Adenoma.

Kwok WY, Hagiwara S, Nishida N, Watanabe T, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Iwanishi M, Chishina H, Kono M, Ueshima K, Komeda Y, Arizumi T, Enoki E, Nakai T, Kumabe T, Nakashima O, Kondo F, Kudo M.

Oncology. 2017;92 Suppl 1:16-28. doi: 10.1159/000451012. Epub 2016 Dec 17.

39.

Contrast-Enhanced Tissue Harmonic Imaging versus Phase Inversion Harmonic Sonographic Imaging for the Delineation of Hepatocellular Carcinomas.

Kono M, Minami Y, Iwanishi M, Minami T, Chishina H, Arizumi T, Komeda Y, Sakurai T, Takita M, Yada N, Ida H, Hagiwara S, Ueshima K, Nishida N, Kudo M.

Oncology. 2017;92 Suppl 1:29-34. doi: 10.1159/000451014. Epub 2016 Dec 15.

40.

Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease.

Hagiwara S, Nishida N, Watanabe T, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Iwanishi M, Chishina H, Ueshima K, Komeda Y, Arizumi T, Kudo M.

Oncology. 2017;92 Suppl 1:3-9. doi: 10.1159/000451010. Epub 2016 Dec 15.

41.

Modular stem fracture at stem-sleeve junction after primary total hip arthroplasty.

Yoshitani J, Nakamura T, Maruhashi Y, Sasagawa T, Ueshima K, Funaki K.

J Orthop Sci. 2016 Oct 25. pii: S0949-2658(16)30190-7. doi: 10.1016/j.jos.2016.10.003. [Epub ahead of print] No abstract available.

PMID:
27789206
42.

Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma.

Nagai T, Arao T, Nishio K, Matsumoto K, Hagiwara S, Sakurai T, Minami Y, Ida H, Ueshima K, Nishida N, Sakai K, Saijo N, Kudo K, Kaneda H, Tamura D, Aomatsu K, Kimura H, Fujita Y, Haji S, Kudo M.

Dig Dis. 2016;34(6):702-707. Epub 2016 Oct 17.

PMID:
27750241
43.

US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases.

Minami Y, Minami T, Chishina H, Kono M, Arizumi T, Takita M, Yada N, Hagiwara S, Ida H, Ueshima K, Nishida N, Kudo M.

Dig Dis. 2016;34(6):687-691. Epub 2016 Oct 17.

PMID:
27750238
44.

Validation of Kinki Criteria, a Modified Substaging System, in Patients with Intermediate Stage Hepatocellular Carcinoma.

Arizumi T, Ueshima K, Iwanishi M, Minami T, Chishina H, Kono M, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Ida H, Sakurai T, Kitano M, Nishida N, Kudo M.

Dig Dis. 2016;34(6):671-678. Epub 2016 Oct 17.

PMID:
27750236
45.

Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver Cirrhosis.

Chishina H, Hagiwara S, Nishida N, Ueshima K, Sakurai T, Ida H, Minami Y, Takita M, Kono M, Minami T, Iwanishi M, Umehara Y, Watanabe T, Komeda Y, Arizumi T, Kudo M.

Dig Dis. 2016;34(6):659-664. Epub 2016 Oct 17.

PMID:
27750234
46.

Monoethanolamine Oleate Sclerotherapy for Polycystic Liver Disease.

Takita M, Iwanishi M, Minami T, Kono M, Chishina H, Arizumi T, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Naoshi N, Kudo M.

Dig Dis. 2016;34(6):654-658. Epub 2016 Oct 17.

PMID:
27750233
47.

Prospective Risk Analysis of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C by Ultrasound Strain Elastography.

Yada N, Sakurai T, Minami T, Arizumi T, Takita M, Hagiwara S, Ida H, Ueshima K, Nishida N, Kudo M.

Dig Dis. 2016;34(6):650-653. Epub 2016 Oct 17.

PMID:
27750232
48.

Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2.

Nishida N, Kono M, Minami T, Chishina H, Arizumi T, Takita M, Yada N, Ida H, Hagiwara S, Minami Y, Ueshima K, Sakurai T, Kudo M.

Dig Dis. 2016;34(6):632-639. Epub 2016 Oct 17.

PMID:
27750230
49.

Outcome of Asunaprevir/Daclatasvir Combination Therapy for Chronic Liver Disease Type C.

Hagiwara S, Nishida N, Watanabe T, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Iwanishi M, Chishina H, Ueshima K, Komeda Y, Arizumi T, Kudo M.

Dig Dis. 2016;34(6):620-626. Epub 2016 Oct 17.

PMID:
27750228
50.

Publisher's Note: Search for Majorana Neutrinos Near the Inverted Mass Hierarchy Region with KamLAND-Zen [Phys. Rev. Lett. 117, 082503 (2016)].

Gando A, Gando Y, Hachiya T, Hayashi A, Hayashida S, Ikeda H, Inoue K, Ishidoshiro K, Karino Y, Koga M, Matsuda S, Mitsui T, Nakamura K, Obara S, Oura T, Ozaki H, Shimizu I, Shirahata Y, Shirai J, Suzuki A, Takai T, Tamae K, Teraoka Y, Ueshima K, Watanabe H, Kozlov A, Takemoto Y, Yoshida S, Fushimi K, Banks TI, Berger BE, Fujikawa BK, O'Donnell T, Winslow LA, Efremenko Y, Karwowski HJ, Markoff DM, Tornow W, Detwiler JA, Enomoto S, Decowski MP; KamLAND-Zen Collaboration.

Phys Rev Lett. 2016 Sep 2;117(10):109903. Epub 2016 Sep 2.

PMID:
27636501

Supplemental Content

Loading ...
Support Center